7.47 USD
↘ 0.39 (4.96%)AT CLOSE (03:59 PM EST)
SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $8.36 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 16, 2026.